From the publishers of JADPRO

HR+ HER2- Breast Cancer Resource Center

Advertisement

Interview with Stephanie Giangiuli, PharmD, BCOP: IV Therapies and Side Effect Management in HR+ HER2- Breast Cancer

Last Updated: Friday, November 15, 2024

Advertisement
News & Literature Highlights
Advertisement
Advertisement